Immunomodulatory drug maintenance therapy vs placebo/observation
All adverse events · people with chronic lymphocytic leukaemia
Immunomodulatory drug maintenance therapy probably leads to higher all adverse events compared with placebo/observation (moderate certainty).
1 finding from 1 review
- Rate ratio 1.41 [1.28, 1.54]3 studies · 458 participantsModerate